BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10725486)

  • 1. Outcome and reproductive function after conservative surgery for borderline ovarian tumors.
    Morris RT; Gershenson DM; Silva EG; Follen M; Morris M; Wharton JT
    Obstet Gynecol; 2000 Apr; 95(4):541-7. PubMed ID: 10725486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
    Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
    BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study.
    Fauvet R; Poncelet C; Boccara J; Descamps P; Fondrinier E; Daraï E
    Fertil Steril; 2005 Feb; 83(2):284-90; quiz 525-6. PubMed ID: 15705364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
    Chan JK; Lin YG; Loizzi V; Ghobriel M; DiSaia PJ; Berman ML
    J Reprod Med; 2003 Oct; 48(10):756-60. PubMed ID: 14619640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infertility treatment after conservative management of borderline ovarian tumors.
    Beiner ME; Gotlieb WH; Davidson B; Kopolovic J; Ben-Baruch G
    Cancer; 2001 Jul; 92(2):320-5. PubMed ID: 11466685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fertility and recurrence results of conservative surgery for borderline ovarian tumors.
    Boran N; Cil AP; Tulunay G; Ozturkoglu E; Koc S; Bulbul D; Kose MF
    Gynecol Oncol; 2005 Jun; 97(3):845-51. PubMed ID: 15896834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
    Vasconcelos I; de Sousa Mendes M
    Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility outcome after conservative surgery for borderline ovarian tumors: a single center experience.
    Kanat-Pektas M; Ozat M; Gungor T; Dikici T; Yilmaz B; Mollamahmutoglu L
    Arch Gynecol Obstet; 2011 Nov; 284(5):1253-8. PubMed ID: 21170543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of conservative surgery for recurrent borderline ovarian tumors.
    Cheng B; Wan X; Qian X; Lv W; Xie X
    Eur J Gynaecol Oncol; 2009; 30(1):75-8. PubMed ID: 19317262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
    Gotlieb WH; Flikker S; Davidson B; Korach Y; Kopolovic J; Ben-Baruch G
    Cancer; 1998 Jan; 82(1):141-6. PubMed ID: 9428490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
    Suh-Burgmann E
    Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasonographic diagnosis and longitudinal follow-up of recurrences after conservative surgery for borderline ovarian tumors.
    Franchi D; Boveri S; Radice D; Portuesi R; Zanagnolo V; Colombo N; Testa AC
    Am J Obstet Gynecol; 2016 Dec; 215(6):756.e1-756.e9. PubMed ID: 27443811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative surgery for borderline ovarian tumors: a review.
    Tinelli R; Tinelli A; Tinelli FG; Cicinelli E; Malvasi A
    Gynecol Oncol; 2006 Jan; 100(1):185-91. PubMed ID: 16216320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary.
    Uzan C; Kane A; Rey A; Gouy S; Duvillard P; Morice P
    Ann Oncol; 2010 Jan; 21(1):55-60. PubMed ID: 19608617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognosis and fertility after conservative treatment for ovarian tumors of limited malignity: review of 68 cases].
    Camatte S; Rouzier R; Boccara-Dekeyser J; Pautier P; Pomel C; Lhomme C; Duvillard P; Castaigne D; Morice P
    Gynecol Obstet Fertil; 2002; 30(7-8):583-91. PubMed ID: 12199041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcome and recurrence after conservative laparoscopic surgery for borderline ovarian tumors.
    Tinelli FG; Tinelli R; La Grotta F; Tinelli A; Cicinelli E; Schönauer MM
    Acta Obstet Gynecol Scand; 2007; 86(1):81-7. PubMed ID: 17230294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
    Chen RF; Li J; Zhu TT; Yu HL; Lu X
    J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility results after conservative treatment of advanced stage serous borderline tumour of the ovary.
    Camatte S; Morice P; Pautier P; Atallah D; Duvillard P; Castaigne D
    BJOG; 2002 Apr; 109(4):376-80. PubMed ID: 12013157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low value of staging in detecting extraovarian occult metastasis in mucinous borderline ovarian tumors.
    Jung HJ; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2020 Nov; 30(11):1780-1783. PubMed ID: 32928923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.